The distribution of microscopic melanoma metastases in sentinel lymph nodes: Implications for pathology protocols

American Journal of Surgical Pathology

Volumn 36, Issue 12, 2012, Pages 1841-1848

  Lobo, Alice Z C ^a   Tanabe, Kenneth K ^a   Luo, Su ^a   Muzikansky, Alona ^a   Sober, Arthur J ^a   Tsao, Hensin ^a   Cosimi, A Benedict ^a   Duncan, Lyn M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

melanoma; metastasis; micrometastasis; sentinel lymph node

Indexed keywords

CANCER STAGING; DIAGNOSTIC PROCEDURE; HUMAN; KAPLAN MEIER METHOD; LABORATORY DIAGNOSIS; LYMPH NODE; LYMPH NODE METASTASIS; MELANOMA; METASTASIS; MICROMETASTASIS; MORTALITY; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENTINEL LYMPH NODE BIOPSY; SKIN TUMOR; STANDARD; TIME; UNITED STATES;

BOSTON; CLINICAL LABORATORY TECHNIQUES; FALSE NEGATIVE REACTIONS; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MELANOMA; NEOPLASM MICROMETASTASIS; NEOPLASM STAGING; PATHOLOGY, CLINICAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; TIME FACTORS;

EID: 84870025277     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31826d25f9     Document Type: Review

References (46)

1. Balch CM, Gershenwald JE, Soong SJ, et al. Update on the melanoma staging system: the importance of sentinel node staging and primary tumor mitotic rate. J Surg Oncol. 2011;104:379-385.
2. Gershenwald J, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999;27:976-983.
3. Balch CM, Gershenwald JE, Soong SJ, et al. Melanoma of the skin. In: Edge SB, Byrd DR, Compton CC, et al, eds. AJCC Cancer Staging Manual. New York: Springer; 2010:325-344.
4. Wargo JA, Tanabe K. Surgical management of melanoma. Hematol Oncol Clin North Am. 2009;23:565-581.
5. Bilimoria KY, Balch CM, Bentrem DJ, et al. Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States. Ann Surg Oncol. 2008;15:1566-1576.
6. Stebbins WG, Garibyan L, Sober AJ. Sentinel lymph node biopsy and melanoma:2010 update Part I. J Am Acad Dermatol. 2010;62:723-734, quiz 735-726.
7. Gershenwald JE, Andtbacka RH, Prieto VG, et al. Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. J Clin Oncol. 2008;26:4296-4303.
8. Riber-Hansen R, Nyengaard JR, Hamilton-Dutoit SJ, et al. The nodal location of metastases in melanoma sentinel lymph nodes. Am J Surg Pathol. 2009;33:1522-1528.
9. Prieto VG, Clark SH. Processing of sentinel lymph nodes for detection of metastatic melanoma. Ann Diagn Pathol. 2002;6:257-264.
10. Shidham VB. Evaluation of sentinel lymph nodes for melanoma metastases by pathologists. Clin Plast Surg. 2010;37:101-112.
11. Wen DR, Cochran AJ, Huang RR, et al. Clinically relevant information from sentinel lymph node biopsies of melanoma patients. J Surg Oncol. 2011;104:369-378.
12. Yu LL, Flotte TJ, Tanabe KK, et al. Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer. 1999;86:617-627.
13. Scolyer RA, Murali R, McCarthy SW, et al. Pathologic examination of sentinel lymph nodes from melanoma patients. Semin Diagn Pathol. 2008;25:100-111.
14. Murali R, Thompson JF, Shaw HM, et al. The prognostic significance of isolated immunohistochemically positive cells in sentinel lymph nodes of melanoma patients. Am J Surg Pathol. 2008;32:1106-1107; author reply 1107-1108.
15. Scheri RP, Essner R, Turner RR, et al. Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma. Ann Surg Oncol. 2007;14:2861-2866.
16. van der Ploeg AP, van Akkooi AC, Rutkowski P, et al. Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria. J Clin Oncol. 2011;29:2206-2214.
17. Elsaesser O, Leiter U, Buettner PG, et al. Prognosis of sentinel node staged patients with primary cutaneous melanoma. PLoS One. 2012;7:e29791.
18. Satzger I, Volker B, Meier A, et al. Prognostic significance of isolated HMB45 or Melan A positive cells in Melanoma sentinel lymph nodes. Am J Surg Pathol. 2007;31:1175-1180.
19. Coldiron BM, Dinehart S, Rogers HW. Sentinel lymph node biopsy and completion lymph node dissection for malignant melanoma are not standard of care. Clin Dermatol. 2009;27:350-354.
20. Abrahamsen HN, Hamilton-Dutoit SJ, Larsen J, et al. Sentinel lymph nodes in malignant melanoma: extended histopathologic evaluation improves diagnostic precision. Cancer. 2004;100:1683-1691.
21. Cook MG, Green MA, Anderson B, et al. The development of optimal pathological assessment of sentinel lymph nodes for melanoma. J Pathol. 2003;200:314-319.
22. Gietema HA, Vuylsteke RJ, de Jonge IA, et al. Sentinel lymph node investigation in melanoma: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol. 2004;57:618-620.
23. Spanknebel K, Coit DG, Bieligk SC, et al. Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis. Am J Surg Pathol. 2005;29:305-317.
24. Batistatou A, Cook MG, Massi D, et al. Histopathology report of cutaneous melanoma and sentinel lymph node in Europe: a web-based survey by the Dermatopathology Working Group of the European Society of Pathology. Virchows Arch. 2009;454:505-511.
25. Mitteldorf C, Bertsch HP, Zapf A, et al. Cutting a sentinel lymph node into slices is the optimal first step for examination of sentinel lymph nodes in melanoma patients. Mod Pathol. 2009;22:1622-1627.
26. Meier A, Satzger I, Volker B, et al. Comparison of classification systems in melanoma sentinel lymph nodes-an analysis of 697 patients from a single center. Cancer. 2010;116:3178-3188.
27. Albertini JJ, Cruse CW, Rapaport D, et al. Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg. 1996;223:217-224.
28. Cochran AJ, Wen DR, Herschman HR. Occult melanoma in lymph nodes detected by antiserum to S-100 protein. Int J Cancer. 1984;34:159-163.
29. Cochran AJ. Surgical pathology remains pivotal in the evaluation of'sentinel' lymph nodes. Am J Surg Pathol. 1999;23:1169-1172.
30. Cochran AJ, Wen DR, Huang RR, et al. Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node. Mod Pathol. 2004;17:747-755.
31. Cochran A, Morton DL. Detection of Clinically Relevant Melanoma Metastases Requires Focused, Not Exhaustive, Evaluation of Sentinel Lymph Nodes. Am J Surg Pathol. 2006;30:419-420.
32. Li LX, Scolyer RA, Ka VS, et al. Pathologic review of negative sentinel lymph nodes in melanoma patients with regional recurrence: a clinicopathologic study of 1152 patients undergoing sentinel lymph node biopsy. Am J Surg Pathol. 2003;27:1197-1202.
33. Morton DL, Thompson JF, Essner R, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lympha-denectomy for early-stage melanoma: a multicenter trail. Multicenter Selective Lymphadenoectomy Trial Group. Arch Surg. 1999; 137:392-399.
34. Scoggins CR, Ross MI, Reintgen DS, et al. Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma. J Clin Oncol. 2006; 24:2849-2857.
35. Kammula US, Ghossein R, Bhattacharya S, et al. Serial follow-up and the prognostic significance of reverse transcriptase-polymerase chain reaction-staged sentinel lymph nodes from melanoma patients. J Clin Oncol. 2004;22:3989-3996.
36. Clary BM, Brady MS, Lewis JJ, et al. Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence. Ann Surg. 2001;233:250-258.
37. Shidham VB, Qi DY, Acker S, et al. Evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma: higher diagnostic accuracy with Melan-A and MART-1 compared with S-100 protein and HMB-45. Am J Surg Pathol. 2001;25:1039-1046.
38. Scolyer RA, Thompson JF, McCarthy SW, et al. Intraoperative frozen-section evaluation can reduce accuracy of pathologic assessment of sentinel nodes in melanoma patients. J Am Coll Surg. 2005;201:821-823; author reply 823-824.
39. van Akkooi AC, de Wilt JH, Verhoef C, et al. Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative? Ann Oncol. 2006;17:1578-1585.
40. Govindarajan A, Ghazarian DM, McCready DR, et al. Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse. Ann Surg Oncol. 2007;14:906-912.
41. Starz H, Balda BR, Kramer KU, et al. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer. 2001;91:2110-2121.
42. Wagner JD, Davidson D, Coleman JJ III, et al. Lymph node tumor volumes in patients undergoing sentinel lymph node biopsy for cutaneous melanoma. Ann Surg Oncol. 1999;6:398-404.
43. Scolyer RA, Li LX, McCarthy SW, et al. Micromorphometric features of positive sentinel lymph nodes predict involvement of nonsentinel nodes in patients with melanoma. Am J Clin Pathol. 2004;122:532-539.
44. van der Ploeg IM, Kroon BB, Antonini N, et al. Is completion lymph node dissection needed in case of minimal melanoma metastasis in the sentinel node? Ann Surg. 2009;249:1003-1007.
45. Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307-1317.
46. Kirkwood JM, Ibrahim JG, Sosman JA, et al. High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801. J Clin Oncol. 2001;19:2370-2380.